Additionally, non-invasive MRI and optical imaging, with tumour-specific accumulation in human epidermal growth factor receptor 2 (HER2)-positive xenografts, is facilitated by HER2-targeted iron oxide nanoparticles tagged with cisplatin [98]. Here, ERBB2 is linked to neoplasm.